Institute for Cancer Research
Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded.
The Institute has internationally strong research groups within biochemistry, cell and tumor biology, genetics, radiation biology, immunology and cancer prevention. For more than 30 years there has been a close interaction between researchers at the Institute and cancer surgeons, oncologists and pathologists. This emphasis on translational science has resulted in numerous clinical protocols based on in-house research, and the Institute is a key partner in the Comprehensive Cancer Center, organizationally under the Division of Surgery and Cancer Treatment at Oslo University Hospital.
Scientific director
Scientific production - Institute for Cancer Research
| PubMed articles | Doctoral theses | |
| 2010 | so far | so far |
| 2009 | 164 | 22 |
| 2008 | 140 | 11 |
| 2007 | 153 | 16 |
| 2006 | 171 | 12 |
| 2005 | 158 | 12 |
The Institute is engaged in both basic and translational cancer research involving experimental research on model organisms from various evolutionary levels as well as human material from all types of cells and tissues. The co-localisation with a large cancer hospital fulfils the premises for advanced medical research across sciences, a necessity towards the goals of individualised diagnostics and treatment for cancer patients.
Go back
Print this page
E-mail this pageAug 31, 2010
Oslo, September 20-22, 2010
Aug 30, 2010
Latest publications
Inst. for Cancer Research
Predicted Risk of Radiation-Induced Cancers after Involved Field and Involved Node Radiotherapy with or without Intensity Modulation for Early-Stage Hodgkin Lymphoma in Female Patients
Int J Radiat Oncol Biol Phys (in press)
PubMed 20800383
Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density
Breast Cancer Res, 12 (4), R65 (in press)
PubMed 20799965
Radiosensitizing Drugs: Lessons to Be Learned From the Oxaliplatin Story
J Clin Oncol (in press)
PubMed 20733124
Selected publications
Journal Impact Factor > 5, first or last author from the Institute for Cancer Research
Radiosensitizing Drugs: Lessons to Be Learned From the Oxaliplatin Story
J Clin Oncol (in press)
PubMed 20733124
(Impact 17.8)
UVRAG mutations associated with microsatellite unstable colon cancer do not affect autophagy
Autophagy, 6 (7) (in press)
PubMed 20724836
(Impact 6.8)
Autophagic degradation of an oncoprotein
Autophagy, 6 (7) (in press)
PubMed 20724820
(Impact 6.8)
